Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

More documents

Recommendations

Info

19278 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 3816 ATC / . DDD MON 2945301 01 TEMOMEDAC CAPS 5MG/CAP BOTTLE x 5 MEDAC GESELLSCH 0.054063 G 0.462 2945301 02 TEMOMEDAC CAPS 5MG/CAP BOTTLE x 20 MEDAC GESELLSCH 0.054063 G 1.850 2945302 01 TEMOMEDAC CAPS 20MG/CAP BOTTLE x 5 MEDAC GESELLSCH 0.054063 G 1.850 2945302 02 TEMOMEDAC CAPS 20MG/CAP BOTTLE x 20 MEDAC GESELLSCH 0.054063 G 7.399 2945303 01 TEMOMEDAC CAPS 100MG/CAP BOTTLE x 5 MEDAC GESELLSCH 0.054063 G 9.249 2945303 02 TEMOMEDAC CAPS 100MG/CAP BOTTLE x 20 MEDAC GESELLSCH 0.054063 G 36.994 2945304 01 TEMOMEDAC CAPS 140MG/CAP BOTTLE x 5 MEDAC GESELLSCH 0.054063 G 12.948 2945304 02 TEMOMEDAC CAPS 140MG/CAP BOTTLE x 20 MEDAC GESELLSCH 0.054063 G 51.792 2945305 01 TEMOMEDAC CAPS 180MG/CAP BOTTLE x 5 MEDAC GESELLSCH 0.054063 G 16.647 2945305 02 TEMOMEDAC CAPS 180MG/CAP BOTTLE x 20 MEDAC GESELLSCH 0.054063 G 66.590 2945306 01 TEMOMEDAC CAPS 250MG/CAP BOTTLE x 5 MEDAC GESELLSCH 0.054063 G 23.121 2945306 02 TEMOMEDAC CAPS 250MG/CAP BOTTLE x 20 MEDAC GESELLSCH 0.054063 G 92.486 ( ) L01AX03 TEMOZOLOMIDE 2411407 01 TEMODAL PD.SOL.INF 2,5MG/ML x 1 BOTTLE MERCK SHARP AND 0.054063 G 1.850 L01B -A ( ) L01BA04 PEMETREXED 2667801 01 ALIMTA PD.C.SO.IN 500MG/VIAL BTX1VIAL ELI-LILLY NEDERLAN 0.04119 G 12.139 L01BB -A L01BB G1 -A / ( ) L01BB04 CLADRIBINE 2221301 01 LEUSTATIN SOL.INF 10MG/10ML BTx7VIALSx10ML JANSSEN-CILAG 0.0063 G 11.111 L01BB G2 -A / ( ) L01BB05 FLUDARABINE PHOSPHATE 2215402 02 FLUDARA F.C.TAB 10MG/TAB BTx20 (BLIST 4x5) GENZYME EUROPE 0.012357 G 16.185
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19279 3816 ATC / . DDD MON ( ) L01BB05 FLUDARABINE PHOSPHATE 2215401 01 FLUDARA PD.I.S.INF 50MG/VIAL BTx5 VIALS GENZYME EUROPE 0.007723 G 32.370 2754801 02 FLUDARABIN/EBEWIN.SO.CR 25MG/ML BT x 5 VIALSx 2 ML EBEWE PHARMA GE 0.007723 G 32.370 2708001 01 FLUDARABINE/TEV C/S.SOL.IN 25MG/ML BTx1 VIALx 2 ML CHEMIPHARM .. 0.007723 G 6.474 2754801 01 FLUDARABIN/EBEWIN.SO.CR 25MG/ML ()BT x 1 VIAL x 2 ML EBEWE PHARMA GE 0.007723 G 6.474 2754801 03 FLUDARABIN/EBEWIN.SO.CR 25MG/ML ()BT x 10VIALS x 2 ML EBEWE PHARMA GE 0.007723 G 64.740 2854001 01 FLUDARABINE/SPE PD.I.S.INF 50MG/VIAL BTx5VIALSx50MG SPECIFAR ABEE 0.007723 G 32.370 L01BB G3 -A / ( , ) L01BB06 CLOFARABINE 2860101 02 EVOLTRA C/S.SOL.IN 20MG (1MG/ML) 2 BTx4 VIALS GENZYME EUROPE 0.010586 G 7.557 2860101 05 EVOLTRA C/S.SOL.IN 20MG (1MG/ML) 2 BTx 1VIAL GENZYME EUROPE 0.010586 G 1.889 L01BB G4 -A / ( ) L01BB07 NELARABINE 2791901 01 ATRIANCE SOL.INF 5MG/ML BTx6 VIALS x50 ML GLAXO GROUP LTD 0.123571 G 12.139 L01BC -A L01BC G1 -A / ( ) L01BC06 CAPECITABINE 2471201 01 XELODA F.C.TAB 150MG/TAB BTx60(BLIST6x10) ROCHE REGISTRAT 4.325 G 2.081 2471202 01 XELODA F.C.TAB 500MG/TAB BTx120(BLIST12x10) ROCHE REGISTRAT 4.325 G 13.873 L01BC G2 -A / ( ) L01BC07 AZACITIDINE 2871101 01 VIDAZA PD.INJ.SUS 25MG/ML BTx1 VIAL x 100MG CELGENE EUROPE L 0.032438 G 3.083
Page 1 and 2:
18959 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥ
Page 3 and 4:
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 319: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
show all

Î¥ÏÎ¿Ï ÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?

Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·